Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Endocrinology · Thyrotropin-Releasing Hormone Resistance Syndrome

Treating TRH Resistance: The Two Golden Rules

At a Glance

TRH resistance is treated with lifelong levothyroxine, but clinicians must assess cortisol function before the first dose because thyroid hormone can trigger adrenal crisis when cortisol is low. Since TSH is unreliable, Free T4, symptoms, growth, and development guide dosing.

The standard treatment for TRH Resistance Syndrome is providing the body with the thyroid hormone it cannot properly signal for on its own. While the biology of the condition is complex, daily management typically involves a single, long-term medication called levothyroxine, a synthetic form of the natural thyroid hormone T4 [1][2].

However, because this is a form of central hypothyroidism, there are two “golden rules” of treatment that differ from common thyroid conditions.

The First Rule: Assess the Adrenals First

The most critical safety requirement before treating central hypothyroidism is evaluating the hypothalamic-pituitary-adrenal axis.

In some pituitary conditions, the body may be low in both thyroid hormone and cortisol (the “stress hormone”) [3]. Thyroid hormone acts like a “gas pedal” for the body’s metabolism [4]. If you push the gas pedal by starting levothyroxine while cortisol levels are low, the body may use up its remaining cortisol too quickly, potentially triggering a life-threatening adrenal crisis [5][6].

Your medical team must evaluate the adrenal axis before the very first dose of levothyroxine is given [3]. Note that a single morning cortisol test is not always definitive; its interpretation depends on age, stress, and illness. If adrenal insufficiency cannot be safely excluded, doctors will start glucocorticoid (steroid) replacement therapy first or simultaneously with the levothyroxine [5].

The Second Rule: Focus on Free T4, Not TSH

In most common thyroid patients, doctors look at TSH (the messenger signal) to see if the medication dose is correct.

In TRH Resistance, this “thermostat” is impaired and cannot be used to monitor treatment. Because the pituitary gland is the source of the signaling problem, TSH levels may stay low or “normal” even if your child needs a higher dose [7][8].

Instead, your specialist will dose based on:

  • Free T4 Levels: The goal is usually to keep the Free T4 in the appropriate range for your child’s age and the specific assay used [2][9].
  • Clinical Symptoms: The doctor will watch for healthy growth, energy levels, and developmental progress [10][11].
  • Blood Test Timing: For the most accurate results, ask your endocrinologist when blood should be drawn relative to the daily dose (e.g., drawing blood before taking the medication) [8].

Managing Levothyroxine Daily

Levothyroxine is a lifelong treatment that is most effective when absorbed consistently.

  • Consistency is Key: Establish a consistent, clinician-approved routine. While giving the medication on an empty stomach is ideal, the most important factor for infants is a routine you can stick to every day [1].
  • Avoid Interference: Keep supplements containing calcium or iron separated from the thyroid dose by several hours, as they block absorption [12]. (If your baby uses soy-based formula, discuss timing with your endocrinologist or pharmacist to find a practical feeding schedule).
  • Missed or Vomited Doses: Ask your doctor for a specific plan on what to do if your child misses a dose, spits it out, or vomits shortly after taking it. Do not double the dose or change the medication amount without medical advice.
  • Formulation Matters: If you switch from a crushed tablet to a liquid, or change brands, your child will likely need a blood test 4 to 6 weeks later to ensure the new version is absorbing correctly [13].

Never adjust the dose based on a home symptom or a TSH lab result alone. With the correct dose and consistent care, levothyroxine effectively bypasses the broken signal and provides the body with the hormone it needs [10].

Common questions in this guide

What medicine is used to treat TRH resistance syndrome?
Most children with TRH resistance syndrome are treated long term with levothyroxine, a synthetic form of the thyroid hormone T4. It supplies the hormone the body cannot signal for effectively, but the dose should be set and adjusted by the treating clinician.
Why should cortisol be checked before my child starts levothyroxine?
Some children with central hypothyroidism may also have too little cortisol, the body’s stress hormone. Starting thyroid hormone when cortisol is low can trigger a life-threatening adrenal crisis, so clinicians may give steroid replacement before or at the same time as levothyroxine if low cortisol cannot be safely ruled out.
Why is Free T4 used instead of TSH to adjust treatment?
The signaling problem in TRH resistance can keep TSH low or within the usual range even when a child needs more thyroid hormone. Clinicians therefore use Free T4, symptoms, growth, energy, and developmental progress to guide dosing, with blood-test timing kept consistent.
How should I give levothyroxine to a child with TRH resistance?
Give levothyroxine on the same clinician-approved schedule each day; an empty stomach may improve absorption, but a consistent routine is especially important for infants. Keep calcium or iron supplements several hours apart, and ask the endocrinologist or pharmacist about timing with soy-based formula.
What should I do if my child misses or vomits a levothyroxine dose?
Ask the treating clinician for a specific plan because instructions may depend on how much medicine was taken and when vomiting occurred. Do not double the next dose or change the amount without medical advice.
Will my child need testing after changing levothyroxine brands or forms?
Changing from a crushed tablet to a liquid or switching brands can alter how much levothyroxine is absorbed. The clinician may order Free T4 testing about 4 to 6 weeks after the change to confirm that the dose is working as intended.

Get notified when new evidence is published on Resistance to thyrotropin-releasing hormone syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Congenital Hypothyroidism: A 2020-2021 Consensus Guidelines Update-An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology.

    van Trotsenburg P, Stoupa A, Léger J, et al.

    Thyroid : official journal of the American Thyroid Association 2021; (31(3)):387-419 doi:10.1089/thy.2020.0333.

    PMID: 33272083
  2. 2

    [Central hypothyroidism].

    Petunina NA, Trukhina LV, Martirosian NS

    Terapevticheskii arkhiv 2019; (91(10)):135-138 doi:10.26442/00403660.2019.10.000358.

    PMID: 32598643
  3. 3

    Subclinical hypothyroidism or central hypothyroidism-The danger of thyroid function misinterpretation.

    Anyiam O, Cheung B, Al-Sabbagh S

    Clinical case reports 2018; (6(10)):1953-1957 doi:10.1002/ccr3.1694.

    PMID: 30349705
  4. 4

    Immune Checkpoint Inhibitor-Induced Hypophysitis Presenting as Severe Hyponatremia: A Nephrology Perspective on Avoiding the Syndrome of Inappropriate Antidiuretic Hormone (SIADH) Pitfall.

    Al Zein S

    Cureus 2026; (18(5)):e109633 doi:10.7759/cureus.109633.

    PMID: 42359175
  5. 5

    A rare association of central hypothyroidism and adrenal insufficiency in a boy with Williams-Beuren syndrome.

    Dayal D, Giri D, Senniappan S

    Annals of pediatric endocrinology & metabolism 2017; (22(1)):65-67 doi:10.6065/apem.2017.22.1.65.

    PMID: 28443262
  6. 6

    Potential pitfalls in diagnosis of immunotherapy-induced hypothalamic-pituitary-adrenal axis abnormalities: a clinical case.

    Bi Y, Adam S, Chatzimavridou V, et al.

    Endocrine oncology (Bristol, England) 2022; (2(1)):K5-K9 doi:10.1530/EO-21-0023.

    PMID: 37435468
  7. 7

    The diagnosis and management of central hypothyroidism in 2018.

    Persani L, Cangiano B, Bonomi M

    Endocrine connections 2019; (8(2)):R44-R54.

    PMID: 30645189
  8. 8

    Routine free thyroxine reference intervals are suboptimal for monitoring children on thyroxine replacement therapy and target intervals need to be assay-specific.

    Wheeler E, Choy KW, Chin LK, et al.

    Scientific reports 2019; (9(1)):19080 doi:10.1038/s41598-019-55690-x.

    PMID: 31836869
  9. 9

    Median-lower normal levels of serum thyroxine are associated with low triiodothyronine levels and body temperature in patients with central hypothyroidism.

    Hirata Y, Fukuoka H, Iguchi G, et al.

    European journal of endocrinology 2015; (173(2)):247-56 doi:10.1530/EJE-15-0130.

    PMID: 25994949
  10. 10

    [Hypothyroidism-when and how to treat?]

    Koehler VF, Reincke M, Spitzweg C

    Der Internist 2018; (59(7)):644-653 doi:10.1007/s00108-018-0438-x.

    PMID: 29872890
  11. 11

    Central Hypothyroidism: Advances in Etiology, Diagnostic Challenges, Therapeutic Targets, and Associated Risks.

    Iglesias P

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2025; (31(5)):650-659 doi:10.1016/j.eprac.2025.02.004.

    PMID: 39947625
  12. 12

    Congenital Hypothyroidism: Screening and Management.

    Rose SR, Wassner AJ, Wintergerst KA, et al.

    Pediatrics 2023; (151(1)) doi:10.1542/peds.2022-060419.

    PMID: 36827523
  13. 13

    Liquid and softgel levothyroxine use in clinical practice: state of the art.

    Virili C, Trimboli P, Romanelli F, Centanni M

    Endocrine 2016; (54(1)):3-14 doi:10.1007/s12020-016-1035-1.

    PMID: 27473098

This page explains treatment and medication monitoring for children with TRH resistance syndrome for informational purposes only and does not constitute medical advice. Follow your child’s endocrinologist’s instructions before starting or changing levothyroxine.